These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1578220)

  • 41. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

  • 44. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Seroepidemiological analysis of hepatitis B among children aged 1-14 in 3 counties of Guangdong province in 2013].
    Shao X; Wu C; Wang F; Liang J; Xie X; Zhu Q; Liu J; Hu P; Qiu Q; Liang X; Zheng H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):777-81. PubMed ID: 26733134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ad hoc survey of hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in 12-year-old subjects in southern Italy.
    Adamo B; Stroffolini T; Sagliocca L; Simonetti A; Iadanza F; Fossi E; Tancredi F; Mele A
    Vaccine; 1998 May; 16(8):775-7. PubMed ID: 9627934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan.
    Lin DB; Wang HM; Lee YL; Ling UP; Changlai SP; Chen CJ
    Vaccine; 1998 Oct; 16(17):1683-7. PubMed ID: 9713947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Matching study on immune response between single anti-HBc positivity and healthy adults after primary immunization and revaccination of hepatitis B vaccine].
    Liu J; Lyu J; Yan B; Feng Y; Zhang L; Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Oct; 35(10):1091-4. PubMed ID: 25567010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy.
    Bonanni P; Colombai R; Gasparini R; Lo Nostro A; Tiscione E; Tomei A; Montomoli E; Comodo N
    Pediatr Infect Dis J; 1999 Aug; 18(8):677-82. PubMed ID: 10462335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term efficacy study of hepatitis B vaccination in newborns--results of 11 years' follow-up].
    Lin X; Xu Z; Ou-Yang P
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Jun; 20(3):174-7. PubMed ID: 10682531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of hepatitis B by immunization of the newborn infant--a long-term follow-up study in Stockholm, Sweden.
    Sangfelt P; Reichard O; Lidman K; von Sydow M; Forsgren M
    Scand J Infect Dis; 1995; 27(1):3-7. PubMed ID: 7784811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure.
    Huang ML; Liao WL; Ho MS
    Vaccine; 2007 Aug; 25(34):6326-33. PubMed ID: 17629600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatitis B revaccination not indicated, even for those at increased risk].
    Isken LD; Zaaijer HL; van Steenbergen JE
    Ned Tijdschr Geneeskd; 2009; 153():A415. PubMed ID: 19900310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.